Takeda Pharmaceutical (TAK) Gross Margin Growth (1y) (2018 - 2026)
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Gross Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.13 Bn | 625.38 Bn | 17.26 Bn | 32.00 |
| 2 | AbbVie | 442.39 Bn | 435.82 Bn | 12.70 Bn | 292.00 |
| 3 | Merck | 366.26 Bn | 359.12 Bn | 12.21 Bn | -396.00 |
| 4 | Novartis Ag | 266.58 Bn | 258.89 Bn | 11.24 Bn | -391.00 |
| 5 | Pfizer | 159.00 Bn | 147.30 Bn | 10.94 Bn | -144.00 |
| 6 | Sanofi | 52.39 Bn | 45.00 Bn | 10.79 Bn | 257.00 |
| 7 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 8 | Incyte | 25.41 Bn | 20.87 Bn | 1.57 Bn | 21.00 |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | -173.00 |
| 10 | Takeda Pharmaceutical | 2.61 Bn | -3.19 Bn | 5.10 Bn | -397.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -397.00 |
| Mar 31, 2026 | -130.00 |
| Dec 31, 2025 | -79.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 592.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 12.00 |
| Sep 30, 2024 | -146.00 |
| Jun 30, 2024 | -137.00 |
| Mar 31, 2024 | -170.00 |
| Dec 31, 2023 | 465.00 |
| Sep 30, 2023 | -14,571.00 |
| Jun 30, 2023 | -559.00 |
| Mar 31, 2023 | -21.00 |
| Dec 31, 2022 | -983.00 |
| Sep 30, 2022 | 14,585.00 |
| Jun 30, 2022 | -293.00 |
| Mar 31, 2022 | 279.00 |
| Dec 31, 2021 | -97.00 |
| Sep 30, 2021 | -16,673.00 |